Table 2 Demographic, clinical, and health behaviour characteristics of AMBER qualitative study participants (n = 21) compared to the AMBER cohort study participants (N = 1,507)
Characteristic | Qualitative sample | AMBER cohort | P | ||
|---|---|---|---|---|---|
(N = 21) | (N = 1,507) | ||||
N (%) | Mean ± SD | N (%) | Mean ± SD | ||
Demographic | |||||
Age at diagnosis | 55.8 ± 13.8 | 55.4 ± 10.8 | 0.876 | ||
Study location | |||||
Edmonton | 13 (61.6) | 632 (8.9) | 0.08 | ||
Calgary | 8 (38.1) | 875 (12.1 | |||
Marital Status | |||||
Married or common-law | 19 (90.5) | 1113 (72.8) | 0.206 | ||
Widowed/separated/divorced | 1 (4.8) | 284 (18.6) | |||
Single/never married | 1 (4.8) | 110 (7.2) | |||
Ethnicity | |||||
Caucasian | 20 (95.2) | 1311 (85.8) | 0.364 | ||
First Nations/Indigenous/Metis | 1 (4.8) | 12 (1) | |||
Education | |||||
High school or below | 2 (9.5) | 3412 (22.4) | 0.142 | ||
College | 6 (28.6) | 481 (31.5) | |||
University | 5 (23.8) | 393 (25.7) | |||
Graduate school | 8 (38.1) | 291 (19) | |||
Annual Family Income | |||||
<$50,000 | 2 (9.5) | 245 (16) | 0.570 | ||
50-100k | 5 (23.8) | 486 (31.8) | |||
100-150k | 6 (28.6) | 353 (23.1) | |||
>150k | 8 (38.1) | 423 (27.7) | |||
Employment Status | |||||
Works < 35 hours per week | 14 (66.7) | 1006 (65.8) | 0.993 | ||
Works ≥ 35 hours per week | 7 (33.3) | 501 (32.8) | |||
Clinical/behavioural | |||||
Body mass index (kg/m2) | 28 ± 4.8 | 27.5 ± 5.6 | 0.716 | ||
Normal weight | 6 (28.6) | 572 (37.4 | 0.378 | ||
Overweight or obese (BMI > 25 kg/m2) | 15 (71.4) | 935 (61.2) | |||
Waist circumference (cm) | 95.6 ± 14.8 | 92.8 ± 13.5 | 0.351 | ||
Waist-to-hip ratio (cm) | 0.89 ± 0.08 | 0.88 ± 0.07 | 0.291 | ||
% body fat | 42 ± 6.7 | 43.1 ± 7.2 | 0.481 | ||
Resting heart rate | 68.2 ± 9.9 | 72.4 ± 10.1 | 0.06 | ||
VO2max (ml/kg/min) | 26.2 ± 6.1 | 25.9 ± 6.2 | 0.852 | ||
MVPA† minutes per day | 69.6 ± 50.3 | 61.1 ± 33.8 | 0.263 | ||
Number of 1st degree relative breast cancer family history | 0.4 ± 0.7 | 0.3 ± 0.6 | 0.983 | ||
Stage | |||||
I | 5 (23.8) | 677 (44.3) | < .001 | ||
II | 9 (42.9) | 703 (46) | |||
III | 7 (33.3) | 127 (8.3) | |||
Histology | |||||
Ductal carcinoma | 15 (71.4) | 1275 (83.4) | 0.272 | ||
Invasive ductal and lobular | |||||
carcinoma mixed | 2 (9.5) | 56 (3.7) | |||
Invasive lobular carcinoma | 4 (19) | 159 (10.4) | |||
Mastectomy | |||||
Yes | 10 (47.6) | 622 (40.7) | 0.558 | ||
No | 11 (52.4) | 885 (57.9) | |||
Chemotherapy | |||||
Yes | 14 (66.7) | 877 (57.4) | 0.434 | ||
No | 7 (33.3) | 630 (41.2) | |||
Neoadjuvant therapy | |||||
Yes | 4 (19) | 113 (7.4) | 0.048 | ||
No | 17 (81) | 1394 (91.2) | |||
Comorbidity score (0–8) | 1.0 ± 1.4 | .92 ± 1.1 | 0.733 | ||
Smoking | |||||
Never smoker | 13 (61.9) | 855 (56) | 0.643 | ||
Past smoker | 8 (38.1) | 541 (35.4) | |||